HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yihebali Chi Selected Research

dimethylarginine

1/2020Longitudinal Pharmacometabonomics for Predicting Malignant Tumor Patient Responses to Anlotinib Therapy: Phenotype, Efficacy, and Toxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yihebali Chi Research Topics

Disease

13Neoplasms (Cancer)
12/2023 - 01/2013
12Disease Progression
12/2023 - 06/2015
11Stomach Neoplasms (Stomach Cancer)
02/2022 - 10/2011
8Hypertension (High Blood Pressure)
10/2021 - 06/2015
7Neoplasm Metastasis (Metastasis)
03/2024 - 01/2013
6Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2024 - 05/2016
5Proteinuria
01/2021 - 11/2018
4Thyroid Neoplasms (Thyroid Cancer)
10/2023 - 10/2016
4Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 06/2015
3Hypertriglyceridemia
12/2023 - 11/2018
3Renal Cell Carcinoma (Grawitz Tumor)
09/2016 - 01/2016
2Carcinoma (Carcinomatosis)
03/2024 - 03/2014
2Rectal Neoplasms (Rectal Cancer)
12/2022 - 01/2022
2Diarrhea
12/2022 - 01/2022
2Thrombocytopenia (Thrombopenia)
12/2022 - 11/2012
2Fatigue
12/2022 - 11/2018
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 10/2016
2Sarcoma (Soft Tissue Sarcoma)
11/2018 - 10/2016
2Adenocarcinoma
06/2015 - 10/2011
1Hemangioblastoma
03/2024
1von Hippel-Lindau Disease (von Hippel Lindau Disease)
03/2024
1Leukopenia
12/2023
1Pancreatic Diseases (Pancreatic Disease)
12/2022
1Hepatocellular Carcinoma (Hepatoma)
06/2022
1Dyspnea (Shortness of Breath)
01/2022
1Leiomyosarcoma
01/2021
1Rare Diseases (Rare Disease)
01/2021
1Respiratory Insufficiency (Respiratory Failure)
11/2020
1Disseminated Intravascular Coagulation
11/2020
1Cachexia
11/2020
1Hepatic Encephalopathy
11/2020
1Hypophosphatemia
08/2020
1medullary Thyroid cancer
11/2018
1Pneumothorax
11/2018
1Hand-Foot Syndrome
11/2018
1Weight Loss (Weight Reduction)
08/2018
1Vomiting
08/2018
1Colonic Neoplasms (Colon Cancer)
10/2016
1Hyperlipidemias (Hyperlipidemia)
06/2016
1Hypercalcemia (Milk Alkali Syndrome)
01/2016
1Anemia
01/2016
1Exanthema (Rash)
06/2015

Drug/Important Bio-Agent (IBA)

9anlotinibIBA
10/2023 - 10/2016
5surufatinibIBA
10/2023 - 11/2020
4Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2015 - 06/2012
3Alanine Transaminase (SGPT)IBA
12/2023 - 06/2015
3Phosphotransferases (Kinase)IBA
12/2023 - 01/2020
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2023 - 06/2015
3Temozolomide (Temodar)FDA LinkGeneric
12/2022 - 01/2018
3Capecitabine (Xeloda)FDA Link
01/2022 - 01/2018
3Tyrosine Kinase InhibitorsIBA
10/2016 - 01/2016
2Angiogenesis InhibitorsIBA
10/2023 - 11/2018
2tyrosine receptor (receptor, tyrosine)IBA
09/2021 - 01/2020
2Biomarkers (Surrogate Marker)IBA
08/2021 - 01/2020
2regorafenibIBA
08/2020 - 06/2015
2Triglycerides (Triacylglycerol)IBA
11/2018 - 10/2016
2Lipase (Acid Lipase)FDA Link
10/2016 - 06/2015
2Fluorouracil (Carac)FDA LinkGeneric
06/2015 - 10/2011
2Cisplatin (Platino)FDA LinkGeneric
06/2015 - 10/2011
2Docetaxel (Taxotere)FDA Link
06/2012 - 10/2011
1Al18F-NOTA-octreotideIBA
03/2024
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
03/2024
1Mechanistic Target of Rapamycin Complex 1IBA
12/2023
1TOR Serine-Threonine KinasesIBA
12/2023
1Thalidomide (Thalomid)FDA Link
12/2022
1Trinitrotoluene (TNT)IBA
01/2022
1Dihydroorotate DehydrogenaseIBA
01/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021
1HMPL-013IBA
01/2021
1Epirubicin (Ellence)FDA LinkGeneric
01/2021
1N- methyl- N- 2- (methylsulfinyl)ethylpropionic acid amide (NMPA)IBA
01/2020
1dimethylarginineIBA
01/2020
1CholesterolIBA
11/2018
1camrelizumabIBA
01/2018
1Sunitinib (Sutent)FDA Link
09/2016
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2016
1LipidsIBA
06/2016
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2016
1GastrinsIBA
05/2016
1lactate dehydrogenase 1 (LDH1)IBA
01/2016
1Leucovorin (Folinic Acid)FDA Link
06/2015
1Sorafenib (BAY 43-9006)FDA Link
06/2015
1nimotuzumabIBA
06/2015
1ErbB Receptors (EGF Receptor)IBA
06/2015
1Therapeutic UsesIBA
03/2014
1taxaneIBA
03/2014
1gambogic acidIBA
01/2013

Therapy/Procedure

8Therapeutics
12/2023 - 11/2012
7Drug Therapy (Chemotherapy)
12/2022 - 10/2011
5Chemoradiotherapy
12/2022 - 08/2018
5Neoadjuvant Therapy
01/2022 - 06/2012
4Radiotherapy
12/2022 - 08/2018
2Lymph Node Excision (Lymph Node Dissection)
10/2021 - 05/2016
1Adjuvant Chemoradiotherapy
10/2021
1Gastrectomy
10/2021
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
10/2021
1Immunotherapy
09/2021
1Oral Administration
09/2021
1Nephrectomy
09/2016
1Combination Drug Therapy (Combination Chemotherapy)
06/2015